CD274 and cancer: PD-L1 CNAs, particularly PD-L1 copy number gains, represent frequent genetic alterations across many cancers, which influence PD-L1 expression levels, are associated with higher mutational loads, and may be exploitable as predictive biomarkers for immunotherapy regimens27.